Page last updated: 2024-10-23

azathioprine and Lipomatosis

azathioprine has been researched along with Lipomatosis in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Lipomatosis: A disorder characterized by the accumulation of encapsulated or unencapsulated tumor-like fatty tissue resembling LIPOMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, GC1
Cooper, T1
Payne, WS1
Greene, ML1
Glueck, CJ1
Fujimoto, WY1
Seegmiller, JE1

Other Studies

2 other studies available for azathioprine and Lipomatosis

ArticleYear
Steroid-induced mediastinal lipomatosis.
    Minnesota medicine, 1973, Volume: 56, Issue:7

    Topics: Azathioprine; Humans; Lipomatosis; Male; Mediastinal Diseases; Middle Aged; Prednisone

1973
Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia.
    The American journal of medicine, 1970, Volume: 48, Issue:2

    Topics: Adult; Azathioprine; Blood Protein Electrophoresis; Carbon Isotopes; Female; Glucose Tolerance Test;

1970